[Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal].
The authors report two cases of active seropositive rheumatoid arthritis who were treated in an early phase of the disease with infliximab plus methotrexate obtaining a clinical remission. The benefit was maintained after the discontinuation of the anti-TNF alpha inhibitor for adverse events, indicating that the early administration of the drug may be followed by a sustained remission.
Istituto di Medicina Interna B, Dipartimento di Medicina Clinica e Sperimentale, Sezione di Reumatologia, Università di Verona. paola.caramaschi@azosp.vr.it
P
P
Caramaschi
S
S
Pieropan
A
A
Volpe
A
A
Carletto
L M
LM
Bambara
D
D
Biasi
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D000911:Antibodies, Monoclonal; D000069285:Infliximab
Due casi di artrite reumatoide trattati in fase precoce con infliximab con mantenimento dell'effetto dopo la sospensione del farmaco.